RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究

周聪; 何丽娜; 成小姣; 黄廷磊; 涂水平

doi:10.19401/j.cnki.1007-3639.2023.07.004

您当前的位置：

首页 >

文章列表页 >

RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究

论著 | 更新时间：2025-12-31

- RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究
- Effect of RSPO3 on inhibiting the growth of colorectal cancer transplanted tumors and increasing NK cell infiltration in vivo
- 中国癌症杂志 2023年33卷第7期页码：664-672
- 作者机构：
  
  1. 上海交通大学医学院附属仁济医院肿瘤科，上海 200127
  2. 复旦大学附属华山医院普外科，上海 200040
- 作者简介：
  
  [ "周聪（ORCID: 0009-0001-0006-2207），硕士，住院医师。" ]
  涂水平（ORCID: 0000-0001-5658-3063），博士，主任医师。
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2023.07.004
  中图分类号： R735.3+5；R735.3+7
- 收稿：2022-10-30，
  
  修回：2023-04-25，
  
  纸质出版：2023-07-30
- 稿件说明：
移动端阅览
周聪, 何丽娜, 成小姣, 等. RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究[J]. 中国癌症杂志, 2023,33(7):664-672.

Cong ZHOU, Lina HE, Xiaojiao CHENG, et al. Effect of RSPO3 on inhibiting the growth of colorectal cancer transplanted tumors and increasing NK cell infiltration in vivo[J]. China Oncology, 2023, 33(7): 664-672.
周聪, 何丽娜, 成小姣, 等. RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究[J]. 中国癌症杂志, 2023,33(7):664-672. DOI： 10.19401/j.cnki.1007-3639.2023.07.004.

Cong ZHOU, Lina HE, Xiaojiao CHENG, et al. Effect of RSPO3 on inhibiting the growth of colorectal cancer transplanted tumors and increasing NK cell infiltration in vivo[J]. China Oncology, 2023, 33(7): 664-672. DOI： 10.19401/j.cnki.1007-3639.2023.07.004.

摘要

背景与目的：

结直肠癌的发生、发展涉及多个癌基因的激活和抑癌基因的失活，野生型R-脊椎蛋白3（R-spondin 3，RSPO3）在结直肠癌生长中的作用目前尚不清楚，本研究旨在探讨RSPO3对结直肠癌生长的影响并探索其潜在机制。

方法：

采用生物信息学分析RSPO3在结直肠癌及泛癌组织中的表达，分析结直肠癌中RSPO3表达与自然杀伤（natural killer，NK）细胞浸润、NK细胞激活分子表达的相关性。利用短发夹RNA（short hairpin RNA，shRNA）和慢病毒感染建立

RSPO

3敲减的SW480-RSPO3-KD细胞株、RSPO3过表达的HCT116-RSPO3-OE细胞株及相应的对照细胞株。采用细胞计数试剂盒-8（cell counting kit-8，CCK-8）检测体外各稳定转染细胞株的细胞增殖。采用流式细胞术分析各稳定转染细胞株的细胞周期、裸小鼠脾脏和移植瘤组织中NK细胞的比例。通过裸小鼠皮下移植瘤模型观察

RSPO

3敲减或过表达的结肠癌细胞在裸小鼠体内的生长。利用双荧光素酶报告基因系统检测

RSPO

3敲减或过表达对结肠癌

Wnt

基因转录活性的影响。

结果：

生物信息学分析显示，

RSPO

3在多种实体瘤肿瘤组织包括结直肠癌组织中的表达显著低于相应的癌旁组织。

RSPO

3敲减或过表达不影响体外SW480和HCT116结肠癌细胞的增殖（

0.05）和细胞周期（

0.05）。但在裸小鼠体内，与对照细胞相比，

RSPO

3敲减显著促进SW480细胞移植瘤的生长（260.2±162.4

1 311.7±570.1，

0.05），而

RSPO

3过表达则显著抑制HCT116细胞移植瘤的生长（1 549.0±241.2

512.1±250.0，

0.05）。流式细胞术分析发现，在荷移植瘤裸小鼠体内，

RSPO

3敲减显著减少了脾脏和移植瘤组织中NK细胞的比例（脾脏：6.42±0.94

5.25±0.59，

=0.04；移植瘤：8.27±0.29

6.48±1.48，

=0.04）；而

RSPO

3过表达显著增加了脾脏和移植瘤组织中NK细胞的比例（脾脏：5.29±0.16

7.02±0.49，

=0.01；移植瘤：6.39±0.39

8.14±0.34，

0.05）。癌症基因组图谱（The Cancer Genome Atlas，TCGA）数据相关性分析显示，

RSPO

3表达与NK细胞表面标志物CD56（

=0.58，

0.05）和CD16（

=0.64，

0.05）的表达显著正相关，并与NK细胞激活标志物CD69（

=0.51，

0.05）和KLRB1（

=0.37，

0.05）的表达显著正相关。双荧光素酶报告基因实验结果显示，

RSPO

3敲减后Wnt荧光素酶活性下调（1.0±0.0

0.45±0.09，

0.05），而

RSPO

3过表达后

Wnt

荧光素酶活性上调（1.0±0.0

1.75±0.14，

0.05）。

结论：

RSPO

3能在体内显著抑制结直肠癌移植瘤的生长，并能增加移植瘤组织中NK细胞浸润，

RSPO

3是一个潜在的结直肠癌的抑制基因。

Abstract

Background and purpose:

The occurrence and development of colorectal cancer involve the activation of multiple oncogenes and the inactivation of tumor suppressor genes. At present

the role of wild-type R-spondin 3 (RSPO3) in the growth of colorectal cancer is still unclear. This study aimed to investigate the effect of RSPO3 on the growth of colorectal cancer and explore the underlying mechanisms.

Methods:

RSPO3 expression in various tumor tissues and adjacent tissues and the relationships between RSPO3 expression and natural killer (NK) cell infiltration and activating molecules in colorectal cancer tissues were analyzed by bioinformatics.

RSPO

3-knockdown SW480 (SW480-RSPO3-KD) and

RSPO

3-overexpressed HCT116 (HCT116-RSPO3-OE) gene modification cell line as well as their control cell lines were established by short hairpin RNA (shRNA) and lentiviral infection. Cell proliferation

in vitro

were detected using cell counting kit-8 (CCK-8). Cell cycle of colon cancer stable cells and the proportion of NK cells in spleen and transplanted tumor tissues of nude mice were determined by flow cytometry. The growth of SW480-RSPO3-KD and HCT116-RSPO3-OE stable cell subcutaneous xenografts

in vivo

was observed in BALB/c nude mice. The

Wnt

gene activity was detected by dual-luciferase reporter system.

Results:

Expression level of

RSPO

3 was low in a variety of solid tumor tissues including colorectal cancer tissues compared to their adjacent normal tissues.

RSPO

3 knockdown or overexpression did not affect cell proliferation (

0.05) and cell cycle in colon cancer cells

in vitro

(

0.05). Surprisingly

RSPO

3 knockdown significantly promoted the growth of SW480 subcutaneous xenograft tumor (260.2±162.4

1 311.7±570.1

0.05).

RSPO

3 overexpression significantly inhibited the growth of HCT116 subcutaneous xenograft tumor (1 549.0±241.2

512.1±250.0

0.05). Flow cytometry analysis showed that the percentages of NK cells in spleen and xenograft tissues were significantly decreased in mice transplanted with

RSPO

3-KD cells compared with control nude mice transplanted with control cells (spleen:6.42±0.94

5.25±0.59

=0.04; transplanted tumor: 8.27±0.29

6.48±1.48

=0.04). The percentage of NK cells was significantly increased in mice transplanted with

RSPO

3-OE cells compared with control mice transplanted with control cells (spleen: 5.29±0.16

7.02±0.49

=0.01; transplanted tumor: 6.39±0.39

8.14 ±0.34

0.05). The Cancer Genome Atlas (TCGA) data analysis showed that expression of

RSPO

3 was positively correlated with the expressions of NK cell markers CD56 (R=0.58

0.05) and CD16 (R=0.64

0.05)

and with the expressions of NK cell activation markers CD69 (R=0.51

0.05) and KLRB1 (R=0.37

0.05).

RSPO

3 knockdown inhibited the activity of Wnt luciferase (1.00±0.00

0.45±0.09

0.05)

and

RSPO

3 overexpression increased the Wnt luciferase activity in colon cancer cells (1.00±0.00

1.75±0.14

0.05).

Conclusion:

RSPO3 can significantly inhibit the growth of colorectal cancer xenograft

in vivo

and increase NK cell frequency and Wnt activity in colon cance

r cells.

RSPO

3 may be a potential colorectal cancer suppressor.

关键词

Keywords

references

AOKI M , MIEDA M , IKEDA T , et al . R-spondin3 is required for mouse placental development [J ] . Dev Biol , 2007 , 301 ( 1 ): 218 - 226 . DOI: 10.1016/j.ydbio.2006.08.018 http://doi.org/10.1016/j.ydbio.2006.08.018

KNIGHT M N , HANKENSON K D . R-spondins: novel matricellular regulators of the skeleton [J ] . Matrix Biol , 2014 , 37 : 157 - 161 . DOI: 10.1016/j.matbio.2014.06.003 http://doi.org/10.1016/j.matbio.2014.06.003

NILSSON K H , HENNING P , EL SHAHAWY M , et al . RSPO3 is important for trabecular bone and fracture risk in mice and humans [J ] . Nat Commun , 2021 , 12 ( 1 ): 4923 . DOI: 10.1038/s41467-021-25124-2 http://doi.org/10.1038/s41467-021-25124-2

KAZANSKAYA O , OHKAWARA B , HEROULT M , et al . The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development [J ] . Development , 2008 , 135 ( 22 ): 3655 - 3664 . DOI: 10.1242/dev.027284 http://doi.org/10.1242/dev.027284

KURTOVA A V , HEINLEIN M , HAAS S , et al . Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis [J ] . Blood Adv , 2023 , 7 ( 4 ): 491 - 507 . DOI: 10.1182/bloodadvances.2022007714 http://doi.org/10.1182/bloodadvances.2022007714 https://ashpublications.org/bloodadvances/article/7/4/491/486075/Disruption-of-stem-cell-niche-confined-R-spondin-3 https://ashpublications.org/bloodadvances/article/7/4/491/486075/Disruption-of-stem-cell-niche-confined-R-spondin-3

LOH N Y , MINCHIN J E N , PINNICK K E , et al . RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro [J ] . Nat Commun , 2020 , 11 ( 1 ): 2797 . DOI: 10.1038/s41467-020-16592-z http://doi.org/10.1038/s41467-020-16592-z

KUROKAWA K , WANG T C , HAYAKAWA Y . R-spondin 3 governs secretory differentiation in the gastric oxyntic glands [J ] . J Clin Invest , 2022 , 132 ( 21 ): e163380 . DOI: 10.1172/JCI163380 http://doi.org/10.1172/JCI163380 https://www.jci.org/articles/view/163380 https://www.jci.org/articles/view/163380

OGASAWARA R , HASHIMOTO D , KIMURA S , et al . Intestinal lymphatic endothelial cells produce R-spondin 3 [J ] . Sci Rep , 2018 , 8 ( 1 ): 10719 . DOI: 10.1038/s41598-018-29100-7 http://doi.org/10.1038/s41598-018-29100-7

GREICIUS G , KABIRI Z , SIGMUNDSSON K , et al . PDGFRα + pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo [J ] . Proc Natl Acad Sci U S A , 2018 , 115 ( 14 ): E3173 - E3181 .

YAN K S , JANDA C Y , CHANG J L , et al . Non-equivalence of Wnt and R-spondin ligands during Lgr5 + intestinal stem-cell self-renewal [J ] . Nature , 2017 , 545 ( 7653 ): 238 - 242 . DOI: 10.1038/nature22313 http://doi.org/10.1038/nature22313 https://www.nature.com/articles/nature22313 https://www.nature.com/articles/nature22313

ANNUNZIATO S , SUN T , TCHORZ J S . The RSPO-LGR4/5-ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease [J ] . Hepatology , 2022 , 76 ( 3 ): 888 - 899 . DOI: 10.1002/hep.32328 http://doi.org/10.1002/hep.32328 https://journals.lww.com/10.1002/hep.32328 https://journals.lww.com/10.1002/hep.32328

KUANG S Q , TONG W G , YANG H , et al . Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia [J ] . Leukemia , 2008 , 22 ( 8 ): 1529 - 1538 . DOI: 10.1038/leu.2008.130 http://doi.org/10.1038/leu.2008.130

KANEDA H , ARAO T , TANAKA K , et al . FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth [J ] . Cancer Res , 2010 , 70 ( 5 ): 2053 - 2063 . DOI: 10.1158/0008-5472.CAN-09-2161 http://doi.org/10.1158/0008-5472.CAN-09-2161

THEODOROU V , KIMM M A , BOER M , et al . MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer [J ] . Nat Genet , 2007 , 39 ( 6 ): 759 - 769 . DOI: 10.1038/ng2034 http://doi.org/10.1038/ng2034

TER STEEGE E J , BOER M , TIMMER N C , et al . R-spondin 3 is an oncogenic driver of poorly differentiated invasive breast cancer [J ] . J Pathol , 2022 , 258 ( 3 ): 289 - 299 . DOI: 10.1002/path.v258.3 http://doi.org/10.1002/path.v258.3 https://onlinelibrary.wiley.com/toc/10969896/258/3 https://onlinelibrary.wiley.com/toc/10969896/258/3

GU H F , TU H , LIU L L , et al . RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer [J ] . Ann Transl Med , 2020 , 8 ( 21 ): 1351 . DOI: 10.21037/atm-20-3731 http://doi.org/10.21037/atm-20-3731

CHEN Z H , ZHOU L J , CHEN L , et al . RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways [J ] . Carcinogenesis , 2019 , 40 ( 2 ): 360 - 369 . DOI: 10.1093/carcin/bgy140 http://doi.org/10.1093/carcin/bgy140

CHEN Z L , ZHANG J Z , YUAN A W , et al . R-spondin 3 promotes the tumor growth of choriocarcinoma JEG-3 cells [J ] . Am J Physiol Cell Physiol , 2020 , 318 ( 3 ): C664 - C674 . DOI: 10.1152/ajpcell.00295.2019 http://doi.org/10.1152/ajpcell.00295.2019 https://journals.physiology.org/doi/10.1152/ajpcell.00295.2019 https://journals.physiology.org/doi/10.1152/ajpcell.00295.2019

TANG Y T , XU Q , HU L , et al . Tumor microenvironment-derived R-spondins enhance antitumor immunity to suppress tumor growth and sensitize for immune checkpoint blockade therapy [J ] . Cancer Discov , 2021 , 11 ( 12 ): 3142 - 3157 . DOI: 10.1158/2159-8290.CD-20-0833 http://doi.org/10.1158/2159-8290.CD-20-0833 https://aacrjournals.org/cancerdiscovery/article/11/12/3142/674712/Tumor-Microenvironment-Derived-R-spondins-Enhance https://aacrjournals.org/cancerdiscovery/article/11/12/3142/674712/Tumor-Microenvironment-Derived-R-spondins-Enhance

SESHAGIRI S , STAWISKI E W , DURINCK S , et al . Recurrent R-spondin fusions in colon cancer [J ] . Nature , 2012 , 488 ( 7413 ): 660 - 664 . DOI: 10.1038/nature11282 http://doi.org/10.1038/nature11282

TANG Y , ZHOU C , LI Q L , et al . Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers [J ] . Oncoimmunology , 2022 , 11 ( 1 ): 2131084 . DOI: 10.1080/2162402X.2022.2131084 http://doi.org/10.1080/2162402X.2022.2131084 https://www.tandfonline.com/doi/full/10.1080/2162402X.2022.2131084 https://www.tandfonline.com/doi/full/10.1080/2162402X.2022.2131084

焦红丽 , 王珺娆 , 胡敏萱 , 等 . SAFB通过调节Wnt信号通路活性促进结直肠癌增殖 [J ] . 临床与实验病理学杂志 , 2022 , 38 ( 4 ): 385 - 391

JIAO H L , WANG J R , HU M X , et al . SAFB promotes colorectal cancer proliferation by regulating Wnt signaling pathway activity [J ] . Chin J Clin Exp Pathol , 2022 , 38 ( 4 ): 385 - 391

RHODES D R , KALYANA-SUNDARAM S , MAHAVISNO V , et al . Oncomine 3.0: genes, pathways, and networks in a collection of 18 000 cancer gene expression profiles [J ] . Neoplasia , 2007 , 9 ( 2 ): 166 - 180 . DOI: 10.1593/neo.07112 http://doi.org/10.1593/neo.07112 https://linkinghub.elsevier.com/retrieve/pii/S1476558607800479 https://linkinghub.elsevier.com/retrieve/pii/S1476558607800479

GHANDI M , HUANG F W , JANÉ-VALBUENA J , et al . Next-generation characterization of the cancer cell line encyclopedia [J ] . Nature , 2019 , 569 ( 7757 ): 503 - 508 . DOI: 10.1038/s41586-019-1186-3 http://doi.org/10.1038/s41586-019-1186-3

RU B B , WONG C N , TONG Y , et al . TISIDB: an integrated repository portal for tumor-immune system interactions [J ] . Bioinformatics , 2019 , 35 ( 20 ): 4200 - 4202 . DOI: 10.1093/bioinformatics/btz210 http://doi.org/10.1093/bioinformatics/btz210

TANG Z F , LI C W , KANG B X , et al . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J ] . Nucleic Acids Res , 2017 , 45 ( W1 ): W98 - W102 . DOI: 10.1093/nar/gkx247 http://doi.org/10.1093/nar/gkx247 https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkx247 https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkx247

RUSSICK J , TORSET C , HEMERY E , et al . NK cells in the tumor microenvironment: prognostic and theranostic impact. Recent advances and trends [J ] . Semin Immunol , 2020 , 48 : 101407 . DOI: 10.1016/j.smim.2020.101407 http://doi.org/10.1016/j.smim.2020.101407 https://linkinghub.elsevier.com/retrieve/pii/S1044532320300233 https://linkinghub.elsevier.com/retrieve/pii/S1044532320300233

OHKAWARA B , GLINKA A , NIEHRS C . RSPO3 binds syndecan 4 and induces Wnt/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis [J ] . Dev Cell , 2011 , 20 ( 3 ): 303 - 314 . DOI: 10.1016/j.devcel.2011.01.006 http://doi.org/10.1016/j.devcel.2011.01.006

浏览量

2612

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

靶向治疗及免疫治疗联合化疗为产AFP阳性结肠癌患者带来显著获益1例病例报告并文献复习

Tepoxalin通过ABCB1影响结直肠癌细胞生长及耐药的分子机制研究

运动干预在结直肠癌患者全程管理中作用的研究进展及展望

基于人工智能辅助腹腔镜右半结肠癌根治术的手术技能评价

结直肠癌新辅助免疫治疗的进展与展望